EP 1015417 A1 20000705 - COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS
Title (en)
COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS
Title (de)
VERBINDUNGEN, DIE SECHSGLIEDRIGE RINGE ENTHALTEN, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
COMPOSES CONTENANT DES CHAINES FERMEES A SIX ELEMENTS, PROCEDES DE PREPARATION DE CES COMPOSES, ET LEUR UTILISATION COMME MEDICAMENTS
Publication
Application
Priority
- US 9819355 W 19980915
- US 5930897 P 19970917
- US 6019597 P 19970926
- US 93864497 A 19970926
Abstract (en)
[origin: WO9914185A1] Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
IPC 1-7
C07C 233/62; C07C 233/63; C07C 279/16; A61K 31/155; A61K 31/16; A61K 31/215
IPC 8 full level
A61K 31/196 (2006.01); A61K 31/00 (2006.01); A61K 31/155 (2006.01); A61K 31/16 (2006.01); A61K 31/215 (2006.01); A61K 31/33 (2006.01); A61K 31/396 (2006.01); A61K 31/445 (2006.01); A61P 31/12 (2006.01); A61P 31/16 (2006.01); A61P 43/00 (2006.01); C07C 233/52 (2006.01); C07C 233/62 (2006.01); C07C 233/63 (2006.01); C07C 247/14 (2006.01); C07C 279/16 (2006.01); C07C 311/14 (2006.01); C07D 203/06 (2006.01); C07D 211/68 (2006.01); C07D 309/28 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP KR)
A61P 31/12 (2018.01 - EP); A61P 31/16 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 233/52 (2013.01 - EP); C07C 233/62 (2013.01 - KR); C07C 233/63 (2013.01 - EP); C07C 279/16 (2013.01 - EP); C07C 2601/16 (2017.05 - EP); Y02P 20/55 (2015.11 - EP)
Citation (examination)
- List P.H.: Arzneiformenlehre, 4. Ed., Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 1985, pages 134-137
- Mathiowitz Edith: Encyclopedia of controlled drug delivery, vol. 1, John Wiley & Sons, Inc., New York, 1999, pages 305-311
- See also references of WO 9914185A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9914185 A1 19990325; AR 013960 A1 20010131; AU 747702 B2 20020516; AU 9569498 A 19990405; BR 9812649 A 20000822; CA 2303323 A1 19990325; CN 1272105 A 20001101; EA 003989 B1 20031225; EA 200000332 A1 20001030; EP 1015417 A1 20000705; ID 25516 A 20001005; IL 134691 A0 20010430; IN 190983 B 20030906; JP 2001516739 A 20011002; KR 20010024123 A 20010326; NZ 502988 A 20020828; TR 200000723 T2 20010621
DOCDB simple family (application)
US 9819355 W 19980915; AR P980104638 A 19980917; AU 9569498 A 19980915; BR 9812649 A 19980915; CA 2303323 A 19980915; CN 98809320 A 19980915; EA 200000332 A 19980915; EP 98949356 A 19980915; ID 20000543 A 19980915; IL 13469198 A 19980915; IN 2791DE1998 A 19980917; JP 2000511738 A 19980915; KR 20007002880 A 20000317; NZ 50298898 A 19980915; TR 200000723 T 19980915